Get started
High Sierra Technologies Inc.HH

High Sierra Technologies Inc.

1.0000USDD
0.00000.00%
At close at Feb 26, 14:43 GMT
USD
No trades
See on Supercharts
Overview
Financials
Discussions Technicals Seasonals

HSTI fundamentals

Key facts

Market capitalization‪20.64 M‬USD
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)−0.40USD
Founded1996
Employees (FY)3
CEOVincent Charles Lombardi
Websitehigh-sierra.com
About

High Sierra Technologies, Inc. engages in the development and licensing of technology for cannabis and hemp products. The company was founded by Vincent C. Lombardi and Gregg W. Koechlein on May 9, 1996 and is headquartered in Reno, NV.

Ownership
‪‪20.64 M‬‬
Closely held shares
‪‪16.16 M‬‬ (78.28%)
Free Float shares
‪‪4.48 M‬‬ (21.72%)
Closely held shares
‪‪16.16 M‬‬ (78.28%)
Free Float shares
‪‪4.48 M‬‬ (21.72%)
Capital structure
Market cap
‪‪20.64 M‬‬
Debt
‪‪671.79 K‬‬
Minority interest
‪890.00‬
Cash & equivalents
‪‪2.22 K‬‬
Enterprise value
‪‪21.31 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪20.64 M‬‬
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
—
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
—
Valuation ratios
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24

Growth and Profitability

Company’s recent performance and margins

Performance
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−8.00 M‬‬
‪‪−6.00 M‬‬
‪‪−4.00 M‬‬
‪‪−2.00 M‬‬
‪0.00‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−1.20 M‬‬
‪‪−900.00 K‬‬
‪‪−600.00 K‬‬
‪‪−300.00 K‬‬
‪0.00‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−1.20 M‬‬
‪‪−900.00 K‬‬
‪‪−600.00 K‬‬
‪‪−300.00 K‬‬
‪0.00‬

Dividends

Dividend yield, history and sustainability

HSTI does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−250.00 K‬‬
‪0.00‬
‪‪250.00 K‬‬
‪‪500.00 K‬‬
‪‪750.00 K‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪250.00 K‬‬
‪‪500.00 K‬‬
‪‪750.00 K‬‬
‪‪1.00 M‬‬
Assets
Liabilities